Modeling Genomic Screening in Newborns

Children with a suspected genetic or undiagnosed disease experience diagnostic odysseys. Genomic sequencing provides a powerful diagnostic tool, thereby decreasing costs related to multiple clinical evaluations, imaging studies, and laboratory tests. This provides psychological benefits for these patients and their families. Genomic sequencing can also complement existing newborn screening programs, however, there are many technical,

April 13th, 2022|

Education for Children with Chronic Illness; Moving Forward in Online and Virtual Learning

Education is an essential component of social development and has an determinant impact on health, particularly, in the case of children.   During the year 2020, thousands of schools and universities transitioned to a fully online learning setting. This situation has affected many students with special education needs which lost appropriate accommodations. Furthermore, some children with

April 13th, 2022|

Depression and Anxiety Disorder in Children and Adolescents

Depression and anxiety are common in children and indicate a problem with mood or anxiety processing. Depression and anxiety disorders can develop in children at any age, from preschool through adolescence. A combination of life experiences, inherited genes, and other factors influence who develops anxiety or depression and when.  Depression and anxiety can cause difficulties

April 13th, 2022|

Memorandum of Understanding between Cittadinanzattiva APS and TEDDY Network

We are very pleased to announce our collaboration with Cittadinanzattiva APS, through its branch, Active Citizenship Network (ACN).   Cittadinanzattiva APS is an Italian civic organization, founded in 1978, which promotes citizens' activism for the protection of rights, the care of common goods, and the support for people in conditions of weakness. In 2001, the Active

April 13th, 2022|

Heads up! New Spanish Code of Conduct on personal data in clinical trials and pharmacovigilance

The Spanish Data Protection Authority published, on last February, the "Code of Conduct on the processing of personal data in the field of clinical trials and other clinical research as well as pharmacovigilance" (CoC). The CoC regulates how data protection rules impact the development of clinical trials and compliance with pharmacovigilance obligations.   Regarding clinical trials,

April 12th, 2022|

Latest TEDDY publication is out!

The European post-authorisation study (EU PAS) register is a repository launched in 2010 by the European Medicines Agency. Multi-database studies (MDS) leveraging secondary data have become an important strategy to conduct post-authorization studies (PAS) in recent years. The “Overview of the European post-authorisation study registerpost-authorization studies performed in Europe fromSeptember 2010 to December 2018”, provides

April 12th, 2022|

My being SPECIAL has lighted me up campaign

Last February 28th we celebrated Rare Disease Day and Kids Bari, the first Young Persons Advisory Group (YPAG) in Italy, joined the #shareyourcolours campaign by making an amazing video showing their Special Colours.   “These Kids and Teens are not defined by their disease, they are not numbers... they are amazing and stunning teens in

April 12th, 2022|

Training on strategies to foster solutions of undiagnosed rare disease cases

As part of the training activities proposed by EJP RD, an online training course on “Training on strategies to foster solutions of undiagnosed rare disease cases” is being organised by Istituto Superiore di Sanità (ISS) in close collaboration with EJP RD partners. The online event will take place over three days from on April 11th – 13th. Through the presentation of sample use cases that

February 3rd, 2022|

Task Force on Disregarded Rare Diseases (Pluto Project)

The Therapies Scientific Committee (TSC) of the International Rare Diseases Research Consortium (IRDiRC) is establishing a Task Force to characterize specific commonalities amongst a large group of “disregarded” rare diseases, with the potential secondary aims to identify removable roadblocks that may foster future research and development. The TSC is specifically looking for members to populate the Task Force with the below expertise in one

February 1st, 2022|